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A B S T R A C T
The aim of this study was to provide an overview of the snakebites in patients hospitalized at the Mostar Clinical Hos-
pital, admitted between 1983 and 2006. A total of 341 patients were recorded, with moderate men predominance (52.8%).
Majority of patients were bitten for the first time (99.1%). In 98.8% of patients snakebite occurred to the bare skin, most
commonly during June to September period (64.2%). Snakebites were the commonest in agricultural workers (48.1%).
Until 2003 all admitted patients were treated according to Russel’s scheme (3-anti). As of 2003 new treatment scheme
was applied, resulting in the reduction of antidote and supportive treatment use, causing a reduction in the number of
clinically apparent allergic reactions. Serum sickness was recorded in only 2 patients, while lethal outcome was recorded
in one (0.3%). Overall results indicate that lethality of snakebite is low, and that patients were often administered treat-
ment without medical indication. High number of tourists as well as the presence of the peace keeping troops and other
visiting personnel in this region make the snakebites and awareness on snakes not only a local issue, but also more gen-
eral concern.
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Introduction
Poisonous snakes inhabit all continents, especially ar-
eas with tropical and sub-tropical climate1–5. Among 3,500
of known snake species, less than 10% are poisonous5. Al-
though the exact figures are unavailable, it is estimated
that almost half a million of snakebites are registered in
the World annually, with 30,000–50,000 lethal outco-
mes5. However, lethal outcomes in the European region
are rare3–5. Within this region, Bosnia and Herzegovina
is characterized by the regular presence of at least two
poisonous snake species, hump-nosed viper (Vipera am-
modytes) and European adder (Vipera berus)6–10. Addi-
tionally, there is a regional variety of European adder
(Vipera berus bosniensis), which is being considered by
some authors as one of the most poisonous snakes in the
European region6,10. Hump-nosed viper and European
adder venom has a necrotizing and hemorrhagic effects,
and a moderate neuro-toxic effect6–12. Local geographic
characteristics and the presence of the favorable climate
are the reason why snakebites are common here in
Bosnia and Herzegovina8,9. Hump-nosed viper is more
commonly reported as a source of the snakebite2,3,9–12,
while European adder bites are less common6–8,10–16. Al-
though the number of affected individuals is lower in the
post-war period compared to the period before the war
outbreak, number of exposed individuals is still high, es-
pecially in the carst mountainous regions. Finally, there
is no uniform and widely accepted treatment scheme for
snakebites2–4,6–8,10–21.
The aim of this paper was to provide basic epidemio-
logical account of snakebites in the region, provide a ret-
rospective overview of the experience gathered during 24
years.
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Materials and Methods
Setting
We investigated the snakebites in the Herzegovina re-
gion, in an area with the total population of 448,878,
which is gravitating to the Mostar Clinical Hospital22,23.
Total study follow-up period was 23 years, from January
1,1983 to December 31, 2006. Area under the study was
9,504 km2, with 47.2 inhabitants per 1 km2 22,23. Addi-
tionally, ever since 1996 and according to Dayton treaty
international peace keeping troops are stationed in Her-
zegovina region. The region is characterized by the carst
regions, lack of surface water and agricultural areas,
scarce pastures and patchy woodland areas24. Finally,
Medjugorje, world known religious location is located in
this region.
Measurements
The study was designed as the retrospective cohort25,26.
Census data from the 1991 and 2000 official census were
used22,23. Patient follow-up was made from the existing
medical and hospital records.
Snakebite reaction in patients was classified accord-
ing to the Reid and Perssons’s scheme15,27. Three stages
of the clinical presentations were assigned: mild, defined
as the patients with only local changes at the bite loca-
tion; moderate, those with severe local reaction, moder-
ate general symptoms and mild changes in the laboratory
findings combined with less than two hours of shock, and
finally severe, characterized by the severe local presenta-
tion, and severe clinical presentation and laboratory fin-
dings and shock that lasted over two hours. Shock was
defined as tachypnoea, perspiration, cyanosis, low blood
pressure, confusion and loss of conscious28. We also re-
corded every case of disseminated intravascular coagu-
lation29,30.
Polyvalent antitoxin was used as the antidote, as it re-
acts to all poisonous snakes in the European region31.
Until 2003, all admitted patients were treated accord-
ing to the 3A scheme (antibiotic, antidote and anti tetanus
serum)1,2,6–12,14. Patients admitted after 2003 were trea-
ted according to newer treatment suggestions5,13,16,17,28,31.
Statistical analysis
For purposes of this study we employed a number of
descriptive methods25,26. Cumulative incidence was cal-
culated for the entire duration of the study, with 95%
confidence intervals. c²-statistics was used in the hypothesis
testing. All analyses were performed in the SPSS package,
with significance set at p<0.01.
Results
During 23 years for which the data was included in
this study, we recorded a total of 389 cases of snakebites,
with equal gender distribution (199 cases or 51.2% men
and 190 or 48.8% women, p=0.326; RR 1.11; 95% CI
0.91–1.35). A total of 358 (92.0%) of patients were re-
ferred by their GPs, while 31 (8.0%) of them came to the
hospital on their own due to the actual bite or just the
fear that they had been bitten, within 4 hours from the
snakebite occurrence. There was no gender difference in
this group either (p=0.215; RR 1.68; 95%; CI 0.82–3.46).
All patients were admitted, and in 341 of them (87.7%)
clinical examination confirmed snakebite, while in 48 of
them (12.3%) we were not able to confirm the snakebite,
suggesting that they have arrived or have been referred
due to possible snakebite or just the fear that they had
been bitten. Post mortem snake species determination
was made in 8.2% of cases, with hump-nose viper being
significantly more common than the adder (93.0% of
cases). A total of 147 (43.1%) patients have reported see-
ing the actual bite without being able to recognize which
species it was, while 23% of patients did not manage to
see the snake at all. Most patients immediately indicated
they had been bitten by hump-nose viper (33.7%).
Medical procedures performed by the GPs were: 6.4%
of patients received immobilization of affected region,
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Fig 1. Area under study.
Fig 2. Snakebite frequency in 1983–2006 period, per 10,000, based
on the population census data from reference items 22 and 23.
18.7% received just antibiotic treatment, and 11.4% re-
ceived just the antidote, while a total of 36.6% received
symptomatic therapy only. Combination of antibiotic and
antidote was recorded in just 14.8% of cases. Neither of
the patients have received tetanus prophylaxis, while
4.8% of them were referred to the hospital by their GPs
without receiving any treatment at all.
Incidence of snakebites varied across investigated pe-
riod, from 6 cases (1.4 per 10,000) in 1992 and 1994 to 26
(5.8 per 10,000) in 1989 (Figure 2). Average annual inci-
dence was 3.3 per 10,000 population. Most bites occurred
during summer months, during July-August period (219;
64.2%), with one bite being recorded even in November
and December (Figure 3).
There was no age related difference in the incidence
of snakebites either, although most cases were middle
aged (41–60 years of age; Table 1). Age range was 3–93
years. Patients occupation profile indicated that the agri-
cultural workers were the most commonly affected (48.1%),
followed by these who were picking mushrooms or other
natural products (23.8%), farmers (14.8%), foresters (6.1%)
and others 7.2% (including a person who got bitten in the
toilet of his holiday home). Most snakebites (99.1%) hap-
pened for the first time in the patients life, and it hap-
pened on the bare skin (98.8%). The commonest bite lo-
cation was fists (52.3%), feet (28.2%), shins (15.2%),
arms (3.7%), while legs and head were the least common
snakebite locations (0.3% each).
A total of 81.2% of patients were received in the mild
clinical appearance, while 4.7% had severe clinical pre-
sentation, without gender differences (Table 2). Most pa-
tients were admitted within 4 hours from the snakebite
(82.1%), also without gender difference (Table 3).
The commonest clinical symptoms included intensive
fear (92.7%), edema, which was massive in 44.3% of
cases, affecting both the limb and torso. Other symptoms
included local edema, regional lymphadenitis (40.8%),
vesiculae (17.0%), skin necrosis (4.1%) and local infec-
tions (1.8%). Systematic symptoms included increased
body temperature and gastrointestinal symptoms (21.7%),
with marked nausea, diarrhea and vomiting. A total of
5.6% of patients were admitted in shock state, while in
2.1% of them it had lasted for over 2 hours. Lab results
showed lekucytosis (31.6%), anemia (7.9%), thrombocy-
topenia (3.2%) and bleeding, which was recorded in uri-
nary tract (7.6%), gastrointestinal (1.5%) and respiratory
system (0.3%). Impaired renal function was recorded in
5.3% of cases (marked by proteinuria, haematuria and
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TABLE 1
NUMBER OF REGISTERED SNAKEBITES IN CLINICAL HOSPITAL MOSTAR, IN THE 1983–2005 PERIOD
Age in years
Comfirmed snakebites (%)
RR (95%CI) p
Men (per 10.000)* Women (per 10.000)* Total (per 10.000)*
0–20 15 (24.5)* 11 (17.7)* 26 (21.1)* 1.38 (0.64–3.01)) 0.531
21–40 31 (40.9)* 17 (24.3)* 48 (32.9)* 1.68 (0.93–3.04) 0.109
41–60 103 (200.9)* 94 (173.7)* 197 (187.0)* 1.16 (0.88–1.53) 0.342
Over 60 31 (104.9)* 39 (87.2)* 70 (94.3)* 1.20 (0.75–1.93) 0.519
Total 180 (82.6)* 161 (69.7)* 341 (76.0)* 1.19 (0.96–1.47) 0.130
Fig 3. Monthly distribution of snakebites for entire investigated
period, 1983–2006.
TABLICA 2
ELAPSED TIME FROM THE BITE TO HOSPITALISATION (IN HOURS), BASED ON THE REGISTERED SNAKEBITES IN CLINICAL
HOSPITAL MOSTAR IN THE 1983–2005 PERIOD
Elapsed time from bite to
hospitalisation (hours)
Number of snakebites (%)
RR (95%CI) p
Men (n=180) Women (n=161) Total (n=341)
0–4 147 (81.7) 133 (82.6) 280 (82.1) 0.99 (0.90–1.09) 0.932
5–8 22 (12.2) 21 (13.0) 43 (12.6) 0.94 (0.54–1.64) 0.948
9–12 10 (5.6) 7 (4.3) 17 (5.0) 1.28 (0.50–3.28) 0.793
12 or more 1 (0.6) – 1 (0.3) – –
Subtotal: within first 8 hours 169 (93.9) 154 (95.7) 323 (94.7) 0.98 (0.93–1.03) 0.628
increased serum creatinine). A total of 8.2% had devel-
oped oliguria. Liver function impairment was recorded in
5.0% of cases, with increased bilirubine and liver enzy-
mes, and decrease serum fibrinogen. Neurotoxical symp-
toms with cranial paresis and paralysis was recorded in
17.9% of cases, most commonly affecting occulomotor
nerve with ptosis.
Until 2003, according to Russel scheme, all patients
have received antidote, antibiotic (penicillin) and tetanus
prophylaxis. Additionally, corticosteroid treatment was
applied in 86.3% and antihistamine in 69.5%. A total of
78.7% of patients have received single antidote treat-
ment, while in 21.3% we administered two or more doses.
Ever since 2003, treatment scheme has changed, with a
total of 50 patients who did not receive antidote in the
treatment scheme. After 2003 only 78.0% of patients
have received antidote, 66.2% had received antibiotic,
while 60.1% had received corticosteroids and antihista-
mine. Tetanus prophylaxis was administered in 12% of
cases, due to high percent of previously administered
vaccines due to warfare activities in the years before.
Serum sickness was recorded in 0.6% of patients,
8th–10th day after serum application. We did not record
any case of anaphylactic shock nor tetanus.
A total of 17.6% of patients have also received surgical
treatment, most commonly bullae incisions (14.1%), ne-
crosis removal (4.7%) and fasciotomy (2.9%), all with
complete recovery.
Only one fatal case was recorded, in 85 years old
woman who was not referred to the hospital, but was
only assisted by the Emergency care, and who after hav-
ing received treatment went back home. After few hours
she lost consciousness, after which she was referred to
the hospital, with the total of 8 hours after the snakebite
occurred. She had previously been removed one kidney,
had hypertension and history of five years of breast can-
cer without proper treatment. Clinical parameters were
showing severe manifestations, including increase levels
of serum glucose (14.3 mmol/L), creatinine of 160 mmol/L,
prolonged thrombin time (16.9 sec with 53.7%). After re-
ceiving proper treatment, the patient became anuric,
with signs of epystaxis. She has also received 260 ml of
erythrocytes. Third day she developed large hematomas
of the arm which started spreading across the torso,
marked by more bleeding, develops shock and passes
away 40 hours after the snakebite took place due to hem-
orrhagic shock and multi-organ failure.
Discussion
This study suggests that most of findings from Herze-
govina are in line with findings from other coun-
tries3,6,11,12,20,38. The principal snakebite exposed popula-
tion group are workers, although the proportion of el-
derly seems to increase, due to large increase in their
number in the population, especially those who are in-
volved in the Asparagus picking2,3,6,8,12. Additionally, this
seems to be also caused by the young people migration
towards larger cities, leaving behind only elderly in the
rural and remote areas, or the direct consequence of the
1992–1995 war. One of the suggestions that are derived
from the results of this study is that workers should wear
protective equipment (primarily gloves), as most snake-
bites have occurred to bare skin. This is also seen in the
finding that during the entire wartime period we did not
detect a single snakebite in the military personnel, sug-
gesting that regular wearing of protective clothing may
reduce the number of snakebite cases. Monthly profile of
snakebites was in line with snake biological cycles, with
most bites during summer months.
The least snakebites happened during active warfare
periods (1992–1995). The direct consequence of the war
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TABLICA 3
CLINICAL PRESENTATION OF SNAKEBITTEN PATIENTS WHO WERE ADMITTED TO CLINICAL HOSPITAL MOSTAR IN 1983–2006
PERIOD
Clinical presentation
Number (%)
RR (95%CI) p
Men (n=180) Women (n=161) Total (n=341)
Mild presentation 27 (15.0) 22 (13.7) 49 (14.4) 1.10 (0.65–1.85) 0.844
Moderate presentation 144 (80.0) 131 (81.4) 277 (81.2) 0.98 (0.89–1.09) 0.856
Severe presentation 9 (5.0) 7 (4.3) 16 (4.7) 1.15 (0.44–3.02) 0.978
Lethal outcome – 1 (0.6) 1 (0.3) – –
Fig 4. Hump-nose viper bite on the right hand in a 36 year-old
female. Oedema, discoloration of skin and ecchymosis of the
whole arm and part of the torso.
was the reduction in the overall socioeconomic standard,
what has caused increased exposure to various natural
sources of food, including picking mushrooms and ber-
ries and more often wild animal hunting, all resulting in
the increased number of bites in the post-war period.
Similar to previous studies5,8,11,12, we had also re-
ported substantial amount of snakebite fear, what proba-
bly had beneficial effects for the time that lasted from the
snakebite to hospital admission, most commonly being
well under 4 hours. This also suggests that psychological
or even psychiatric treatment should be acknowledge as
the integral part of the snakebite treatment11,14,16. This is
further supported by the finding that a total of 7.7% of
patients came to the hospital on their own and 4.4% were
referred by their GPs, and in both groups we were unable
to confirm snakebites, suggesting that the snakebite fear
is very high in this population.
Clinical presentation was most commonly moderate,
without any gender differences. Symptoms were the con-
sequence of dual nature of snake toxins – more pro-
nounced haematotoxicity and less often expressed neu-
rotoxicity6–9,11–14,16,19,20. All patients have reported local
pain, and most of them had hematoma (Figure 4). Favor-
able clinical outcome is seen in only one fatal case during
the entire period, which was aggravated by the presence
of previous disease in the medical history.
The results of this study show that the treatment
scheme applied by GPs was not unified, what is also seen
in the hospital treatment algorithms. Prior to 2003,
treatment scheme included local snakebite actions (poi-
son suction, cryotherapy, incision)1,6–12,14,18–20, which has
not been shown to have substantial improvement. As of
2003, treatment scheme has been changed5,13,16,17. This
includes administration of antidote, which has been redu-
ced due to possibility of serious adverse effects8,11–13,16,20,31.
Although skin tests have no confirmed value in predict-
ing serum sickness6,13,16, we nevertheless performed them
it in every case. ELISA antigen testing in order to asses
the severity of clinical presentation has been recom-
mended perilously34. Although we acknowledge possible
benefits of this treatment, financial and organizational
difficulties were the reason why this was not done. Anti-
dote was then administered most commonly intramuscu-
lar, and in severe clinical manifestations we sometimes
also applied it intravenously31. In line with previous
studies, usefulness of antidote was the highest if applied
up to 4 hours after the bite13,16,31, when single dose can be
sufficient in moderate clinical manifestations.
As of 2003, antibiotic treatment was applied only in
cases that local infection was present, with marked skin
necrosis or abscesses, thus reducing routine antibiotic
application5,13,16,17,21. Penicillin was most commonly ad-
ministered, or other antibiotics based on the antibio-
gramme (most commonly cephalosporines). Despite sug-
gestions that anti-tetanus vaccination is not suggested as
there are no known post-bite cases of tetanus5,8,11–13,16,
we performed this in those who had not received it re-
lated to 1992–1995 war35, what was the general suggest-
ing that we tried to follow in every treatment case. Besi-
des these, we also tried to deliver appropriate symptoms
therapy, reduce fear, pain, maintain good liquid intake,
and prevent development of shock. After 2003, treatment
costs have gone down too, due to reduced number of al-
lergic reactions.
Despite not being highly lethal, we still believe that
snakebites in Herzegovina region do not receive appro-
priate attention among medical professionals, leading to
inappropriate immediate treatment and low amount of
information on this, including insufficient education of
health personnel. This situation could be substantially
improved by the development and application of guide-
lines. Additionally, WHO suggestions indicate that sna-
kebite information should be collected, and that espe-
cially tourists and temporary migrants (including foreign
soldiers) should be informed about the risks snakebites
in certain areas. This information should also be deliv-
ered to religion tourists, who present the major number
of people visiting Medjugorje every year.
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UGRIZI ZMIJA NA MOSTARSKOM PODRU^JU, BOSNA I HERECEGOVINA
S A @ E T A K
Cilj ovog istra`ivanja bio je prikazati pojavnost zmijskih ugriza me|u pacijentima koji su bili hospitalizirani u Kli-
ni~koj bolnici Mostar, u razdoblju 1983.–2006. godine. Ukupno je tijekom tog razdoblja zabilje`en 341 pacijent, s ne{to
ve}im brojem mu{karaca (52,8%). Ve}ini pacijenata to je bio prvi ugriz (99,1%). Tako|er, kod ve}ine pacijenata ugriz se
dogodio na golu ko`u, najvi{e tijekom ljetnih mjeseci. Ugrizi su bili naj~e{}i kod poljoprivrednika (48,1%). Do 2003.
godine pacijetni su lije~eni Russelovom shemom lije~enja, a od 2003. godine kori{ten je novi oblik lije~enja koji je bio
obilje`en manjom koli~inom kori{tenja zmijskog protuotrova i smanjenjem broja alergijskih reakcija. Serumska bolest
zabilje`ena je samo kod dva pacijenta, a smrtni ishod samo kod jednog (0,3%). Sveukupni rezultati govore u prilog
malom mortalitetu i da je pacijentima ~esto primjenjeno lije~enje bez stvarne indikacije. Veliki broj turista i vojnog
osoblja u ovom podru~ju je razlog zbog kojeg pojavnost zmijskih ugriza nije samo lokalni nego i mnogo {iri problem.
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